PL1915156T3 - Zastosowanie środków pobudzających psychomotorycznie i zawierających je kompozycji w sposobie leczenia rodzących ssaków łożyskowych w celu zmniejszenia wycieńczenia matki i/lub macicy - Google Patents

Zastosowanie środków pobudzających psychomotorycznie i zawierających je kompozycji w sposobie leczenia rodzących ssaków łożyskowych w celu zmniejszenia wycieńczenia matki i/lub macicy

Info

Publication number
PL1915156T3
PL1915156T3 PL06783947T PL06783947T PL1915156T3 PL 1915156 T3 PL1915156 T3 PL 1915156T3 PL 06783947 T PL06783947 T PL 06783947T PL 06783947 T PL06783947 T PL 06783947T PL 1915156 T3 PL1915156 T3 PL 1915156T3
Authority
PL
Poland
Prior art keywords
order
compositions containing
placental mammals
psychomotor stimulants
reduce maternal
Prior art date
Application number
PL06783947T
Other languages
English (en)
Inventor
Kempen Theo Van
Original Assignee
Provimi Holding B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provimi Holding B V filed Critical Provimi Holding B V
Publication of PL1915156T3 publication Critical patent/PL1915156T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06783947T 2005-08-15 2006-08-14 Zastosowanie środków pobudzających psychomotorycznie i zawierających je kompozycji w sposobie leczenia rodzących ssaków łożyskowych w celu zmniejszenia wycieńczenia matki i/lub macicy PL1915156T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US70795405P 2005-08-15 2005-08-15
EP05107485 2005-08-15
PCT/NL2006/050201 WO2007021189A2 (en) 2005-08-15 2006-08-14 Method of treating parturient placental mammals in order to reduce maternal and/or utirine exhaustion
EP06783947A EP1915156B1 (en) 2005-08-15 2006-08-14 Use of psychomotor stimulants and compositions containing them in a method of treating parturient placental mammals in order to reduce maternal and/or uterine exhaustion

Publications (1)

Publication Number Publication Date
PL1915156T3 true PL1915156T3 (pl) 2012-12-31

Family

ID=35457797

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06783947T PL1915156T3 (pl) 2005-08-15 2006-08-14 Zastosowanie środków pobudzających psychomotorycznie i zawierających je kompozycji w sposobie leczenia rodzących ssaków łożyskowych w celu zmniejszenia wycieńczenia matki i/lub macicy

Country Status (7)

Country Link
EP (1) EP1915156B1 (pl)
AR (1) AR057755A1 (pl)
BR (1) BRPI0615204A2 (pl)
CA (1) CA2615121C (pl)
ES (1) ES2388786T3 (pl)
PL (1) PL1915156T3 (pl)
WO (1) WO2007021189A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ753824A (en) * 2016-11-09 2022-08-26 Charles Sturt Univ Livestock supplement and use thereof
CN107950849B (zh) * 2018-01-17 2021-06-11 清华大学 一种产妇电解质能量饮料及其入量管理方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
CN1227490A (zh) * 1996-08-07 1999-09-01 协和发酵工业株式会社 含有黄嘌呤衍生物的脂肪乳剂
CN1406131A (zh) * 2000-12-25 2003-03-26 株式会社资生堂 活化交感神经的香料组合物
US20040180077A1 (en) * 2003-03-05 2004-09-16 Riker Donald K. Rapidly dissolving edible strips for treating obesity
US20040258765A1 (en) * 2003-06-23 2004-12-23 Gee Gilbert C. Method for treatment of sores and lesions of the skin

Also Published As

Publication number Publication date
CA2615121C (en) 2013-05-07
WO2007021189A3 (en) 2007-04-19
EP1915156A2 (en) 2008-04-30
WO2007021189A2 (en) 2007-02-22
EP1915156B1 (en) 2012-07-11
BRPI0615204A2 (pt) 2013-01-08
CA2615121A1 (en) 2007-02-22
AR057755A1 (es) 2007-12-19
ES2388786T3 (es) 2012-10-18

Similar Documents

Publication Publication Date Title
IL187982A0 (en) Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions
IL198008A0 (en) Methods and compositions for treatment of bone defects with placental cell populations
GB2456375B (en) Method of fetal and maternal ECG identification over multiple epochs
HK1187252A1 (zh) 用胎盤細胞群治療骨缺損的方法和組合物
EP2155235A4 (en) OXYGEN GENERATING COMPOSITIONS FOR INCREASING THE SURVIVAL OF IN VIVO CELLS AND TISSUES
IL204566A (en) Adherent cells from fat or placenta tissue for use in healing
GB0607885D0 (en) Improvements in or relating to uterine manipulators & dilators
ZA200811082B (en) Methods and compositions related to determination and use of white blood cell counts
IL229255A (en) Use of sodium arsenite sodium to make a pharmacological preparation for tissue or organ rejection and treatment kit
HK1153234A1 (zh) 來自胎盤組織的粘附細胞及其在治療中的應用
EP1962698A4 (en) BONE ANCHOR FOR USE IN THE FIXING OF SOFT PARTS TO BONE
HK1198773A1 (zh) 來源於胎盤的貼壁細胞及其在疾病治療中的應用
HRP20190076T1 (hr) Obogaćivanje i identifikacija fetalnih stanica u majčinoj krvi i ligandi za takvu uporabu
EP1965830A4 (en) USE OF ALKALINE PHOSPHATASE FOR MAINTAINING HEALTHY TISSUE MASS IN MAMMALS
EP2427167A4 (en) METHOD AND COMPOSITION FOR RECOVERING AGED-INFUSED TISSUE LOSS IN THE FACE OR PARTICULAR BODY RANGE
GB0526151D0 (en) Improvements in or relating to surgical instruments
PL1915156T3 (pl) Zastosowanie środków pobudzających psychomotorycznie i zawierających je kompozycji w sposobie leczenia rodzących ssaków łożyskowych w celu zmniejszenia wycieńczenia matki i/lub macicy
WO2007039124A3 (en) Compositions comprising colostrum and hyaluronic acid for the treatment of vaginal dryness
EP2357252A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT AND DIAGNOSIS OF HEMORRHAGIC TRANSFORMATION
EP2324063A4 (en) NON-INVASIVE FETAL RHD GENOTYPING FROM MATURE FULL BLOOD
GB0602108D0 (en) Improvements in methods for diagnosis and treatment of vessel occlusion
GB2411834B (en) Composition for use in the treatment of dry skin conditions
EP2061309A4 (en) COMPOSITIONS AND USES THEREFORE FOR REMOVING TICKS FROM EPIDERMAL TISSUE
SI1787649T1 (sl) Uporaba estradiolvalerata v kombinaciji z dienogestom za oralno terapijo disfunkcionalne maternične krvavitve skupaj z oralno kontracepcijo
PL2116133T3 (pl) Zastosowanie środka do zwiększania zawartości alfa kwasu, albo zawartości olejku chmielowego w chmielu